PATENT CLAIM ANALYSIS

Application Number: 15754838
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["546", "300000"]

Abstract:
Some novel compounds are provided in this disclosure. These novel compounds have potential SHP-1 agonist activity for being used in treating cancer.

Claim (Index 15):
The compound of  claim 14 , wherein the haloalkyl group is CF 3 .

Metadata:
- Claim Count in Document: 21.0
- Percentile: 88.0
- Lexical Diversity: 1.2
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14235620', '15620761', '12086792', '14403014', '16325218']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7898487926816365
- 35 USC 102 Novelty (BERT): 0.5009843838233697
- Combined Prediction Score: 0.7609623517958098
- Mean Citation Score: 241.377862
- Max Citation Score: 253.30516
- Similarity Product: 178.26394782031775

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test